{
    "id": 6658,
    "name": "pulmonary large cell neuroendocrine carcinoma",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        "5721"
    ],
    "termId": "DOID:6658",
    "evidence": [
        {
            "id": 3951,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD7451 treatment inhibited proliferation of a lung large-cell neuroendocrine carcinoma cell line expressing Ntrk2 in culture (PMID: 25054037).",
            "molecularProfile": {
                "id": 5968,
                "profileName": "NTRK2 positive"
            },
            "therapy": {
                "id": 2680,
                "therapyName": "AZD7451",
                "synonyms": null
            },
            "indication": {
                "id": 6658,
                "name": "pulmonary large cell neuroendocrine carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 792,
                    "pubMedId": 25054037,
                    "title": "Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25054037"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 3952,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD7451 treatment did not inhibit proliferation of a lung large-cell neuroendocrine carcinoma cell line with reduced Ntrk1 and Ntrk2 expression level in culture (PMID: 25054037).",
            "molecularProfile": {
                "id": 16587,
                "profileName": "NTRK1 dec exp NTRK2 dec exp"
            },
            "therapy": {
                "id": 2680,
                "therapyName": "AZD7451",
                "synonyms": null
            },
            "indication": {
                "id": 6658,
                "name": "pulmonary large cell neuroendocrine carcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 792,
                    "pubMedId": 25054037,
                    "title": "Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25054037"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02279433",
            "title": "A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b",
            "phase": "Phase I",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 4343,
                    "therapyName": "DS6051b",
                    "synonyms": null
                }
            ]
        }
    ]
}